Compare DSGX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSGX | GRFS |
|---|---|---|
| Founded | 1981 | 1940 |
| Country | Canada | Spain |
| Employees | N/A | 25247 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.5B |
| IPO Year | 1999 | N/A |
| Metric | DSGX | GRFS |
|---|---|---|
| Price | $67.60 | $7.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $105.22 | $10.15 |
| AVG Volume (30 Days) | 473.5K | ★ 590.7K |
| Earning Date | 06-03-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.05 | $4.49 |
| Revenue Next Year | N/A | $6.42 |
| P/E Ratio | $37.05 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $62.56 | $7.39 |
| 52 Week High | $117.35 | $11.14 |
| Indicator | DSGX | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 41.37 | 39.40 |
| Support Level | $62.69 | $7.39 |
| Resistance Level | $75.06 | $9.78 |
| Average True Range (ATR) | 2.33 | 0.22 |
| MACD | -0.71 | -0.06 |
| Stochastic Oscillator | 22.23 | 16.06 |
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.